BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Titan Pharmaceuticals Partners With Molteni to Market Probuphine in Europe

  Titan and Molteni expect to enter into the definitive license and distribution agreement during the first quarter of 2018.

  November 28, 2017

   · 

  5 min read
• Nuvo Pharma Commences Trading on the OTCQX Market in the U.S.

  Nuvo’s common shares will continue to trade on the Toronto Stock Exchange under the symbol “NRI”.

  November 28, 2017

   · 

  4 min read
• Drug Development

  Viking Therapeutics Announces Positive Top-Line Results From Phase II Study of VK5211 in Patients Recovering From Hip Fracture

  Top-line data showed that the trial achieved its primary endpoint, demonstrating statistically significant, dose dependent increases in lean body mass, less head, following treatment with VK5211 as compared to placebo.

  November 28, 2017

   · 

  8 min read
• Deals

  Sample6 Pathogen DETECT Platform Acquired by IEH

  This divestment allows Sample6 to focus exclusively on its groundbreaking and highly-regarded CONTROL food safety software.

  November 28, 2017

   · 

  2 min read
• Business

  Appili Therapeutics Appoints Seasoned Biotech Executive Ian C. Mortimer to its Board

  Mr. Mortimer is a seasoned biotechnology executive with proven abilities in leading capital market transactions. He will serve as chair of Appili’s audit committee.

  November 28, 2017

   · 

  2 min read
• 

  Biotech Bay

  Bay Area’s Qool Therapeutics Scores $8M for Targeted Temperature Management System

  The funding was provided by Zhongji Holdings LTD/Join Medical Technology, TAMCAP LLC, BrilliMedical International Corp., BioPacific Investors, Western Technology Investment, and FundRx.

  November 28, 2017

   · 

  3 min read
• Business

  Vir Biotechnology Appoints Herbert W. “Skip” Virgin Executive Vice President and Chief Scientific Officer

  The appointment is effective January 1, 2018.

  November 28, 2017

   · 

  4 min read
• 

  Business

  MedLumics Appoints Medtech Vet James Greene as New CEO

  Greene joins MedLumics from Seroba Lifesciences, a venture capital firm based in Dublin, where he was a partner.

  November 28, 2017

   · 

  6 min read
• Easton Pharma / Alliance Group Awaits Equipment Delivery, Days Away From Commencing Operations on its Aggregate Contract After Closing $1.3M JV Agreement for 50% Property Ownership Interest and Various Business

  Once delivered, operations will commence which should then allow for additional contracts currently under negotiations to close.

  November 28, 2017

   · 

  5 min read
• BioMidwest

  Importance of Quantitative Analysis in Breast Imaging Highlighted in Clinical and Research Results Presented at RSNA

  Four abstracts highlighted the use of Volpara’s quantitative analysis tools for breast imaging.

  November 28, 2017

   · 

  4 min read